Molecular biomarkers for the prognosis of breast cancer: role of amino acid metabolism genes

The development of precise molecular biomarkers for breast cancer prognosis holds immense potential to improve treatment outcomes. This study aimed to investigate the role of amino acid metabolism genes as predictive markers for breast cancer prognosis and their association with the immune-tumour mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of physiology and biochemistry Jg. 81; H. 2; S. 441 - 457
Hauptverfasser: Zhou, Yudong, Yu, Shibo, Zhu, Lizhe, Wang, Yalong, Duan, Chenglong, Li, Danni, Du, Jinsui, Zhang, Jiaqi, Zhang, Jianing, Ma, Ruichao, He, Jianjun, Ren, Yu, Wang, Bin
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Dordrecht Springer Netherlands 01.05.2025
Springer Nature B.V
Schlagworte:
ISSN:1138-7548, 1877-8755, 1877-8755
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The development of precise molecular biomarkers for breast cancer prognosis holds immense potential to improve treatment outcomes. This study aimed to investigate the role of amino acid metabolism genes as predictive markers for breast cancer prognosis and their association with the immune-tumour microenvironment. By employing advanced machine learning algorithms and bioinformatics analysis techniques, the impact of amino acid metabolism-related genes (AAMRGs) on the immune status and overall survival of patients with breast cancer was examined. An AAMRG-based risk model was established to assess the prognostic significance. Validated risk models (AIMP2, IYD, and QARS1) accurately predicted patient outcomes [1 y: 0.87 (0.96–0.78); 3 y: 0.82 (0.87–0.76); 5 y: 0.80 (0.86–0.75)]. Furthermore, this study revealed evidence suggesting that QARS1 may influence breast cancer cell proliferation through methionine metabolism. This analysis provides valuable insights into the mechanisms of breast cancer, emphasizing the significance of AAMRGs as prognostic biomarkers and potential therapeutic targets for optimizing personalized treatment strategies. Key points The development of precise molecular biomarkers for the prognosis of patients with breast cancer holds immense potential in enhancing the outcomes of breast cancer treatment. This study employed machine learning algorithms and bioinformatics analysis techniques to conduct a comprehensive examination of AAMRGs and their impact on the immune status and overall survival of patients with breast cancer. A risk model predicated on AAMRGs was developed to assess their prognostic significance and could markedly bolster the personalized treatment approach for patients with breast cancer.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1138-7548
1877-8755
1877-8755
DOI:10.1007/s13105-025-01088-5